Leveraging synthetic lethality for the development of novel cancer therapies

被引：0
|
作者：
Briggs, Kimberly
机构：
来源：
MOLECULAR CANCER THERAPEUTICS | 2024年 / 23卷 / 12期
关键词：
D O I：
10.1158/1538-8514.CANCERCHEM24-IA002
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
IA002
引用
收藏
页数：2
相关论文
共 50 条
  • [21] A novel synthetic lethality treatment strategy for metastatic breast cancer
    Zonneville, Justin
    Wang, Moyi
    Alruwaili, Mohammed
    Eng, Kevin
    Melendy, Thomas
    Park, Ben Ho
    Iyer, Renuka
    Fountzilas, Christos
    Bakin, Andrei V.
    CANCER RESEARCH, 2021, 81 (13)
  • [22] Development of Metabolic Synthetic Lethality and Its Implications for Thyroid Cancer
    Ju, Sang-Hyeon
    Lee, Scong Eun
    Kang, Yea Eun
    Shong, Minho
    ENDOCRINOLOGY AND METABOLISM, 2022, 37 (01) : 53 - 61
  • [23] Synthetic lethality: Killing cancer with cancer
    Garber, K
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2002, 94 (22) : 1666 - 1668
  • [24] Searching for synthetic lethality in cancer
    Brough, Rachel
    Frankum, Jessica R.
    Costa-Cabral, Sara
    Lord, Christopher J.
    Ashworth, Alan
    CURRENT OPINION IN GENETICS & DEVELOPMENT, 2011, 21 (01) : 34 - 41
  • [25] Synthetic Lethality in Ovarian Cancer
    Chandrasekaran, Akshaya
    Elias, Kevin M.
    MOLECULAR CANCER THERAPEUTICS, 2021, 20 (11) : 2117 - 2128
  • [26] Complex synthetic lethality in cancer
    Ryan, Colm J.
    Devakumar, Lovely Paul Solomon
    Pettitt, Stephen J.
    Lord, Christopher J.
    NATURE GENETICS, 2023, 55 (12) : 2025 - 2026
  • [27] Complex synthetic lethality in cancer
    Colm J. Ryan
    Lovely Paul Solomon Devakumar
    Stephen J. Pettitt
    Christopher J. Lord
    Nature Genetics, 2023, 55 : 2039 - 2048
  • [28] Synthetic Lethality in Cancer Therapeutics
    Beijersbergen, Roderick L.
    Wessels, Lodewyk F. A.
    Bernards, Rene
    ANNUAL REVIEW OF CANCER BIOLOGY, VOL 1, 2017, 1 : 141 - 161
  • [29] Novel Synthetic Lethality Approaches for Drug Combinations and Early Drug Development
    Ocana, Alberto
    Pandiella, Atanasio
    CURRENT CANCER DRUG TARGETS, 2017, 17 (01) : 48 - 52
  • [30] Using KRAS synthetic lethality to design novel therapeutic approaches to cancer
    Costa-Cabral, Sara
    Marinari, Eliana
    Aarts, Marieke
    Riffell, Jenna L.
    Torrence, Christopher
    Lord, Christopher L.
    Ashworth, Alan
    MOLECULAR CANCER THERAPEUTICS, 2013, 12 (05)
12345